“Delara Motlagh is an amazing human being, and an exceptionally bright and talented professional who can build trusted relationships better than anyone i have ever known in my professional or personal life. I had the pleasure of attending the Graduate program at the Kellogg School of Management with Delara, and witnessed her ability to build genuine relationships based on her character, and intelligence. Her unique ability to dissect, complex cross functional problems was an asset for her team, and a testament to her professional experience. She brought her years of experience, as a commercial manager at tier-1 healthcare organizations, to strengthen arguments, and to deliver real world solutions to difficult business problems. I will always cherish my relationship with Delara as a dear friend, and a trusted advisor.”
About
GLOBAL COMMERCIAL LEADER | GENERAL MANAGER
With more than 18 years in various…
With more than 18 years in various…
Activity
-
I recently spoke to Endpoints News founder John Carroll about my views on the #CDMO industry more broadly and what’s ahead for Catalent Pharma…
I recently spoke to Endpoints News founder John Carroll about my views on the #CDMO industry more broadly and what’s ahead for Catalent Pharma…
Liked by Delara Motlagh
-
Listen now! This week, Amy Gamber, VP of Manufacturing, joined CorrDyn’s Data in Biotech for an informative podcast highlighting Atara’s cutting-edge…
Listen now! This week, Amy Gamber, VP of Manufacturing, joined CorrDyn’s Data in Biotech for an informative podcast highlighting Atara’s cutting-edge…
Liked by Delara Motlagh
-
Don’t miss this live webinar to hear our President and CEO, Alessandro Maselli, discuss the evolving role CDMOs play in the biopharmaceutical market,…
Don’t miss this live webinar to hear our President and CEO, Alessandro Maselli, discuss the evolving role CDMOs play in the biopharmaceutical market,…
Liked by Delara Motlagh
Experience & Education
-
Catalent Pharma Solutions
View Delara’s full experience
See their title, tenure and more.
or
Publications
-
Clinical Parameters Influencing Cell Mobilization and Impact of Mobilization Ability on Efficacy Outcomes: An Analysis from ACT-34 CMI
American Heart Association 2012 Meeting Abstract (05 NOV 2012)
Languages
-
English
Full professional proficiency
-
Persian
Professional working proficiency
Recommendations received
1 person has recommended Delara
Join now to viewMore activity by Delara
-
ARM has just wrapped up a fantastic week of team-building at our offsite, celebrating achievements and reviewing what's in store for the rest of…
ARM has just wrapped up a fantastic week of team-building at our offsite, celebrating achievements and reviewing what's in store for the rest of…
Liked by Delara Motlagh
-
ExCellThera announces that the Market Authorization Application (#MAA) for #UM171 Cell Therapy has been accepted by the #EMA under accelerated…
ExCellThera announces that the Market Authorization Application (#MAA) for #UM171 Cell Therapy has been accepted by the #EMA under accelerated…
Liked by Delara Motlagh
-
Dear Network I'm thrilled to announce my new professional chapter at GVS Filter Technology as Blood Business Unit Director! I want to thank GVS…
Dear Network I'm thrilled to announce my new professional chapter at GVS Filter Technology as Blood Business Unit Director! I want to thank GVS…
Liked by Delara Motlagh
-
Suman Subramanian discusses major achievements that have propelled the gene therapy market forward, focusing on establishing reliable manufacturing…
Suman Subramanian discusses major achievements that have propelled the gene therapy market forward, focusing on establishing reliable manufacturing…
Liked by Delara Motlagh
-
BREAKING: Today, we announced the U.S. FDA has expanded the product label for our gene therapy and more people may be able to receive treatment…
BREAKING: Today, we announced the U.S. FDA has expanded the product label for our gene therapy and more people may be able to receive treatment…
Liked by Delara Motlagh
-
In this episode of “The Top Line”, Fierce Pharma interviews Delara Motlagh, head of cell therapy at Catalent and other industry experts. The…
In this episode of “The Top Line”, Fierce Pharma interviews Delara Motlagh, head of cell therapy at Catalent and other industry experts. The…
Liked by Delara Motlagh
-
Poor leadership can often manifest as a tendency to micromanage and exert control over every aspect of a team. For instance, I've noticed instances…
Poor leadership can often manifest as a tendency to micromanage and exert control over every aspect of a team. For instance, I've noticed instances…
Liked by Delara Motlagh
-
As I’m heading back to Boston, I have some time to reflect on a week in the office with our SmartCella colleagues. I’m always humbled by the amazing…
As I’m heading back to Boston, I have some time to reflect on a week in the office with our SmartCella colleagues. I’m always humbled by the amazing…
Liked by Delara Motlagh
-
We are excited to announce new data at the 2024 European Hematology Association (EHA) Congress on our CRISPR/Cas9 gene-edited treatment, along with…
We are excited to announce new data at the 2024 European Hematology Association (EHA) Congress on our CRISPR/Cas9 gene-edited treatment, along with…
Liked by Delara Motlagh
-
At IB, strategic, creative influence is at the core of our brand. Working with Fierce Pharma, we were able to showcase our influence and introduce…
At IB, strategic, creative influence is at the core of our brand. Working with Fierce Pharma, we were able to showcase our influence and introduce…
Liked by Delara Motlagh
-
“The Top Line” podcast by Fierce Pharma recently released the second part of a three-part series exploring the latest advancements in cell and gene…
“The Top Line” podcast by Fierce Pharma recently released the second part of a three-part series exploring the latest advancements in cell and gene…
Liked by Delara Motlagh
-
Big thanks to Fierce Pharma for the recently released “The Top Line” podcast, the second part of a three-part series exploring the latest…
Big thanks to Fierce Pharma for the recently released “The Top Line” podcast, the second part of a three-part series exploring the latest…
Liked by Delara Motlagh
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More